You can read about this (or watch the video) at various places. One is TheFocalPoints.com.
“84.4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months”
It just sounds too good to be true. And you know want that usually means. I’ve not done a deep dive into this report but I’m very skeptical. The study lumped a bunch of different cancer types together: breast, pancreas, colon, lung, etc. The uneducated among us may think all cancers are alike. They are not. They behave differently and, traditionally, require different therapeutic approaches for the best outcome. If (and that’s a big IF) there is a unifying underlying chemical or cellular phenomenon that causes all cancers, then a panacea like ivermectin/mebendazole may be an effective treatment. (In case you’re wondering, I was prepared to take ivermectin during the pandemic but never did.)
Just a reminder, I am not a cancer specialist. If I had cancer, I would consult a cancer specialist, typically an oncologist.
Authors of the study at hand do note that “…these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials are warranted to validate these observations and further define optimal dosing strategies.” You may recognize one of the authors, TV celebrity Dr. Drew Pinsky. What a Renaissance man! Other familiar author names are Peter McCullough and Harvey Risch.
Dr. David Weinberg at Science Based Medicine has done a deep dive and concluded:
This is a shoddy research study presented as a quality improvement project. This dubious classification functioned as an excuse for lack of interface with relevant regulatory bodies.
There is validity to the assertion that ivermectin and mebendazole show anticancer activity in preclinical studies. This study provides no meaningful evidence for or against the efficacy of such treatments in humans with cancer.
—–Steve Parker, M.D.
Paleo Diabetic 